MedTrace Logo

24-Week Water Aerobics Program for Adults and Older Adults at Different Intensity Levels

NCT06529354 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-07-31

No results posted yet for this study

Summary

This goal of this clinical trial is to verify the best way to do water aerobics with adults and older adults. It wants to answer these questions:

* Is high-intensity water aerobics better than water aerobics performed at moderate intensity?
* Does a 24-week water aerobics program improve muscle strength, body weight, fat mass, triglycerides, cholesterol, blood pressure, and quality of life for adults and older adults?

Participants must:

* Do water aerobics at high or moderate intensity, twice a week for 45 minutes per class, for 24 weeks.
* Be assessed before starting the water aerobics program and after it ends to see if there are gains in muscle strength, body weight, fat mass, triglycerides, cholesterol, blood pressure, and quality of life.

It was believed that all variables would get better after doing water aerobics, no matter the intensity. It was also expected that doing higher-intensity water aerobics would lead to larger gains in all measurements compared to moderate-intensity.

Conditions

  • Healthy

Interventions

BEHAVIORAL

Moderate-intensity Group

In water aerobics sessions, the exercises are performed at a moderate intensity, between 60% and 70% of the participant's maximum heart rate predicted by their age.

BEHAVIORAL

High-intensity Group

In water aerobics sessions, the exercises are performed at a high intensity, between 80% and 90% of the participant's maximum heart rate predicted by their age.

Sponsors & Collaborators

  • University of Beira Interior

    lead OTHER

Principal Investigators

  • Luís Faíl · University of Beira Interior

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-30
Primary Completion
2023-07-21
Completion
2023-07-28

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06529354 on ClinicalTrials.gov